140 related articles for article (PubMed ID: 37522577)
1. Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study.
Koyama J; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Nishiyama H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2023 Nov; 30(11):1044-1050. PubMed ID: 37522577
[TBL] [Abstract][Full Text] [Related]
2. Health-Related Quality of Life in Testicular Cancer Survivors in Japan: A Multi-Institutional, Cross-Sectional Study Using the EORTC QLQ-TC26.
Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Yamada S; Nishimura K; Nonomura N; Nishiyama H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Urology; 2021 Oct; 156():173-180. PubMed ID: 33785401
[TBL] [Abstract][Full Text] [Related]
3. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
4. Danish translation and pilot testing of the European Organization for Research and Treatment of Cancer QLQ-TC 26 (EORTC QLQ-TC26) questionnaire to assess health-related quality of life in patients with testicular cancer.
Bager L; Elsbernd A; Nissen A; Daugaard G; Pappot H
Health Qual Life Outcomes; 2018 Jun; 16(1):128. PubMed ID: 29914500
[TBL] [Abstract][Full Text] [Related]
5. Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy.
Nonomura N; Nishimura K; Takaha N; Inoue H; Nomoto T; Mizutani Y; Nakao M; Okuyama A; Miki T
Int J Urol; 2002 Oct; 9(10):539-44. PubMed ID: 12445231
[TBL] [Abstract][Full Text] [Related]
6. Association of financial toxicity with quality of life in testicular cancer survivors.
Nezu K; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Negoro H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2022 Dec; 29(12):1526-1534. PubMed ID: 36102302
[TBL] [Abstract][Full Text] [Related]
7. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26.
Holzner B; Efficace F; Basso U; Johnson CD; Aaronson NK; Arraras JI; Smith AB; Chow E; Oberguggenberger AS; Bottomley A; Steiner H; Incrocci L; Giesinger JM
Qual Life Res; 2013 Mar; 22(2):369-78. PubMed ID: 22407356
[TBL] [Abstract][Full Text] [Related]
8. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders.
Dimitropoulos K; Karatzas A; Papandreou C; Daliani D; Zachos I; Pisters LL; Tzortzis V
Andrologia; 2016 May; 48(4):425-30. PubMed ID: 26268684
[TBL] [Abstract][Full Text] [Related]
9. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
Stepanian S; Patel M; Porter J
Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
[TBL] [Abstract][Full Text] [Related]
10. Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
Eur Urol Oncol; 2020 Jun; 3(3):382-389. PubMed ID: 31506250
[TBL] [Abstract][Full Text] [Related]
11. [LINGUISTIC VALIDATION OF JAPANESE VERSION OF EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE-TESTICULAR CANCER 26 (EORTC QLQ-TC26)].
Arai Y; Yamashita S; Fujii S; Suzukamo Y; Nakamura T; Kawai K; Yamada S
Nihon Hinyokika Gakkai Zasshi; 2017; 108(3):128-136. PubMed ID: 30033975
[TBL] [Abstract][Full Text] [Related]
12. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer.
Pettus JA; Carver BS; Masterson T; Stasi J; Sheinfeld J
Urology; 2009 Feb; 73(2):328-31; discussion 331-2. PubMed ID: 19022490
[TBL] [Abstract][Full Text] [Related]
13. Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes.
Woldu SL; Moore JA; Ci B; Freifeld Y; Clinton TN; Aydin AM; Singla N; Laura-Maria K; Hutchinson RC; Amatruda JF; Sagalowsky A; Lotan Y; Arriaga Y; Margulis V; Xie Y; Bagrodia A
Eur Urol Oncol; 2018 Aug; 1(3):242-251. PubMed ID: 31058267
[TBL] [Abstract][Full Text] [Related]
14. Fertility and reproductive technology use in testicular cancer survivors in Japan: A multi-institutional, cross-sectional study.
Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Yamada S; Nishimura K; Nonomura N; Kojo K; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2021 Oct; 28(10):1047-1052. PubMed ID: 34278620
[TBL] [Abstract][Full Text] [Related]
15. International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer.
van Leeuwen M; Kieffer JM; Efficace F; Fosså SD; Bolla M; Collette L; Colombel M; De Giorgi U; Holzner B; van de Poll-Franse LV; van Poppel H; White J; de Wit R; Osanto S; Aaronson NK; ; ;
Health Qual Life Outcomes; 2017 May; 15(1):97. PubMed ID: 28490338
[TBL] [Abstract][Full Text] [Related]
16. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
[TBL] [Abstract][Full Text] [Related]
17. Impact of cancer therapy on post-treatment ejaculation disorder and sexual life in testicular cancer survivors.
Koyama J; Yamashita S; Yamada S; Fujii S; Goto T; Katayama H; Satake Y; Sato T; Shimada S; Kawasaki Y; Kawamorita N; Mitsuzuka K; Arai Y; Ito A
Int J Urol; 2021 Jan; 28(1):69-74. PubMed ID: 33131119
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
[TBL] [Abstract][Full Text] [Related]
19. Post-chemotherapy nerve-sparing retroperitoneal lymph node dissection for advanced germ cell tumor.
Miki T; Mizutani Y; Nakamura T; Kawauchi A; Nagahara A; Nonomura N; Okuyama A
Int J Urol; 2009 Apr; 16(4):379-82. PubMed ID: 19191930
[TBL] [Abstract][Full Text] [Related]
20. [Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity].
Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C
Urologe A; 2013 Aug; 52(8):1097-103. PubMed ID: 23416965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
